Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Source:http://linkedlifedata.com/resource/pubmed/id/16080467

Download in:

View as

General Info

PMID
16080467